2016 Clinic Diabetes Patient-Centered 
The Medical Futurist
JUNE 21, 2025
The California-based firm, Second Sight , the German company, Retina Implant AG, and the French venture, Pixium Vision were the forerunners of the field, developing implantable visual prosthetics to restore vision to patients who are blind as a result of the rare condition of retinitis pigmentosa.
FDA Law Blog
SEPTEMBER 13, 2021
Controlling Medicare Part D Patient Out-of-Pocket Costs and Total Drug Costs. The Plan supports legislative action to control total drug costs and patient out-of-pocket (“OOP”) costs for Medicare Part D beneficiaries. Controlling Drug Price Increases. Other legislative proposals included improving supply chain transparency.
Expert insights. Personalized for you.
105 
Let's personalize your content